These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 8976868)
1. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity. Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868 [TBL] [Abstract][Full Text] [Related]
2. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
3. Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression. Yasui W; Akama Y; Yokozaki H; Semba S; Kudo Y; Shimamoto F; Tahara E Pathol Int; 1997 Jul; 47(7):470-7. PubMed ID: 9234386 [TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status. Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E J Exp Ther Oncol; 1996 Mar; 1(2):88-94. PubMed ID: 9414392 [TBL] [Abstract][Full Text] [Related]
5. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations. Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083 [TBL] [Abstract][Full Text] [Related]
6. p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix. Werness BA; Wang HQ; Chance J; Goldstein DJ Mod Pathol; 1997 Jun; 10(6):578-84. PubMed ID: 9195575 [TBL] [Abstract][Full Text] [Related]
7. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis. Lu X; Toki T; Konishi I; Nikaido T; Fujii S Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534 [TBL] [Abstract][Full Text] [Related]
8. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. Arai N; Mitomi H; Ohtani Y; Igarashi M; Kakita A; Okayasu I Mod Pathol; 1999 Jun; 12(6):604-11. PubMed ID: 10392637 [TBL] [Abstract][Full Text] [Related]
9. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients. Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971 [TBL] [Abstract][Full Text] [Related]
10. Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma. Hayashi H; Miyamoto H; Ito T; Kameda Y; Nakamura N; Kubota Y; Kitamura H Am J Pathol; 1997 Aug; 151(2):461-70. PubMed ID: 9250158 [TBL] [Abstract][Full Text] [Related]
11. Mutated p53 protein expression and proliferative activity in advanced gastric cancer. Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058 [TBL] [Abstract][Full Text] [Related]
12. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma. Cheng JD; Werness BA; Babb JS; Meropol NJ Clin Cancer Res; 1999 May; 5(5):1057-62. PubMed ID: 10353738 [TBL] [Abstract][Full Text] [Related]
13. p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma. Rey MJ; Fernández PL; Jares P; Muñoz M; Nadal A; Peiró N; Nayach I; Mallofré C; Muntané J; Campo E; Estapé J; Cardesa A J Pathol; 1998 Mar; 184(3):265-71. PubMed ID: 9614378 [TBL] [Abstract][Full Text] [Related]
14. Expression of cell-cycle regulators, cyclin E and p21WAF1/CIP1, potential prognostic markers for gastric cancer. Jang SJ; Park YW; Park MH; Lee JD; Lee YY; Jung TJ; Kim IS; Choi IY; Ki M; Choi BY; Ahn MJ Eur J Surg Oncol; 1999 Apr; 25(2):157-63. PubMed ID: 10218458 [TBL] [Abstract][Full Text] [Related]
15. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma. Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083 [TBL] [Abstract][Full Text] [Related]
16. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Murakami K; Mitomi H; Yamashita K; Tanabe S; Saigenji K; Okayasu I Am J Clin Pathol; 2001 Feb; 115(2):224-34. PubMed ID: 11211611 [TBL] [Abstract][Full Text] [Related]
17. p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx. Nadal A; Jares P; Cazorla M; Fernández PL; Sanjuan X; Hernandez L; Pinyol M; Aldea M; Mallofré C; Muntané J; Traserra J; Campo E; Cardesa A J Pathol; 1997 Oct; 183(2):156-63. PubMed ID: 9390027 [TBL] [Abstract][Full Text] [Related]
18. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis. Cho JH; Kim WH Pathol Res Pract; 1998; 194(5):309-17. PubMed ID: 9651943 [TBL] [Abstract][Full Text] [Related]
19. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers. Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584 [TBL] [Abstract][Full Text] [Related]
20. Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors. Buchynska LG; Nesina IP; Yurchenko NP; Bilyk OO; Grinkevych VN; Svintitsky VS Exp Oncol; 2007 Mar; 29(1):49-53. PubMed ID: 17431389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]